Advair hfa and Meropenem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Advair hfa and Meropenem. Common interactions include weight decreased among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people who take Advair hfa and Meropenem have. It is created by eHealthMe based on reports of 47 people who take Advair hfa and Meropenem from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

47 people who take Advair hfa and Meropenem together, and have interactions are studied.


What is Advair hfa?

Advair hfa has active ingredients of fluticasone propionate; salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 61,105 Advair hfa users for its effectiveness, alternative drugs and more.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 26,723 Meropenem users for its effectiveness, alternative drugs and more.

Number of Advair hfa and Meropenem reports submitted per year:

Advair hfa and Meropenem drug interactions.

Common Advair Hfa and Meropenem drug interactions by gender *:

female:

  1. Weight decreased
  2. Acne
  3. Blood glucose decreased
  4. Blood pressure decreased
  5. Chronic kidney disease
  6. Drug ineffective
  7. Dysphagia
  8. Erythema
  9. Fatigue
  10. Injection site reaction

male:

  1. Drug ineffective
  2. Dyspnoea
  3. Asthenia
  4. Atrial flutter
  5. Dizziness
  6. Pancreatitis
  7. Anaemia
  8. Arthralgia
  9. Bronchiectasis
  10. Chest discomfort

Common Advair Hfa and Meropenem drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood glucose increased
  2. Blood urea decreased
  3. Bronchial wall thickening
  4. Cystic fibrosis
  5. Drug level increased
  6. Forced expiratory volume decreased
  7. Protein total decreased
  8. Vitamin e decreased
  9. White blood cell count decreased
  10. Cough

20-29:

n/a

30-39:

  1. Abdominal pain upper
  2. Nausea
  3. Anxiety
  4. Constipation
  5. Dysphonia
  6. Gastrooesophageal reflux disease
  7. Haemoglobin decreased
  8. Infective pulmonary exacerbation of cystic fibrosis
  9. Insomnia
  10. Leukocytosis

40-49:

  1. Chronic kidney disease

50-59:

n/a

60+:

  1. Dyspnoea
  2. Cough
  3. Pain in jaw
  4. Pyrexia
  5. Sputum increased
  6. Vitamin a deficiency
  7. Wheezing
  8. Influenza like illness
  9. Aphonia
  10. Bronchiectasis

Common conditions people have *:

  1. Cystic Fibrosis (disease of the secretary glands): 26 people, 55.32%
  2. Cystic Fibrosis Lung (fibrosis with cyst in the lung): 16 people, 34.04%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 34.04%
  4. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 16 people, 34.04%
  5. Breathing Difficulty: 12 people, 25.53%
  6. High Blood Pressure: 11 people, 23.40%
  7. Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 11 people, 23.40%
  8. Cough: 10 people, 21.28%
  9. Pain: 9 people, 19.15%
  10. Cystic Fibrosis Related Diabetes: 8 people, 17.02%

* Approximation only. Some reports may have incomplete information.

Do you take Advair hfa and Meropenem?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Advair hfa and Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Advair hfa interactions:

Browse all interactions between Advair hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Meropenem interactions:

Browse all interactions between Meropenem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate; salmeterol xinafoate and meropenem (the active ingredients of Advair hfa and Meropenem, respectively), and Advair hfa and Meropenem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Advair hfa and Meropenem.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: